US Patent 11427610 Cyclic dinucleotides as anticancer agents
Patent 11427610 was granted and assigned to Bristol-Myers Squibb on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114276100
Date of Patent
August 30, 2022
0Patent Application Number
168490910
Date Filed
October 16, 2018
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114276100
Date of Patent
August 30, 2022
0Patent Application Number
168490910
Date Filed
October 16, 2018
0Patent Primary Examiner
Edits on 31 Aug, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11427610 Cyclic dinucleotides as anticancer agents
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11427610
Date of Patent
August 30, 2022
Patent Application Number
16849091
Date Filed
October 16, 2018
Patent Primary Examiner
Find more entities like US Patent 11427610 Cyclic dinucleotides as anticancer agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
